<p>自从 <strong>Appier Group, Inc.</strong> (TSE:4180) 发布年度报告以来，其股票经历了重大抛售，股价下跌 21%，至 JP¥794。整体结果并不理想。尽管 JP¥44 亿的收入符合分析师的预测，但盈利低于预期，未能达到法定估计，下降 20%，每股收益为 JP¥25.14。分析师通常会在每次财报发布时更新他们的预测，我们可以根据他们的估计判断他们对公司的看法是否发生了变化，或者是否有新的关注点。我们认为读者会发现分析师最新的（法定）财报后对明年的预测很有趣。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现的各个方面进行研发。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前投资。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/705511966-earnings-and-revenue-growth-1-dark-2/1771365243126?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/705511966-earnings-and-revenue-growth-1-dark-2/1771365243126"/></p>
<p>TSE:4180 收益和收入增长 2026 年 2 月 17 日</p>
<p>根据最新的结果，Appier Group 的六位分析师现在预测 2026 年的收入为 JP¥540 亿。这将比过去 12 个月的收入大幅增长 23%。每股收益预计将跃升 94%，达到 JP¥48.59。在发布此报告之前，分析师曾预测 2026 年的收入为 JP¥553 亿，每股收益（EPS）为 JP¥52.50。考虑到收入预测的减少和每股收益预期的小幅下降，分析师们的乐观程度不如之前。</p>
<p>查看我们对 Appier Group 的最新分析</p>
<p>共识目标价下降了 8.4%，降至 JP¥1,450，疲软的盈利前景显然导致了估值预期的降低。然而，过于关注单一目标价可能是不明智的，因为共识目标实际上是分析师目标价的平均值。因此，一些投资者喜欢查看估计范围，以了解对公司估值是否存在分歧意见。对 Appier Group 的看法存在一些差异，最乐观的分析师将其估值为 JP¥1,800，而最悲观的分析师则为每股 JP¥1,250。显然，对该股票的看法存在不同，但我们认为估计范围并不够宽泛，以至于暗示情况无法预测。</p>
<p>现在从更大的角度来看，我们可以通过将这些预测与过去的表现和行业增长预期进行比较来理解它们。显然，市场预期 Appier Group 的收入增长将大幅放缓，预计到 2026 年底的年化收入增长为 23%。相比之下，过去五年的历史增长率为 30%。与行业内其他有分析师覆盖的公司相比，后者预计年均收入增长为 9.9%。因此，尽管 Appier Group 的收入增长预计会放缓，但仍然预计会比行业整体增长得更快。</p>
<h2>结论</h2>
<p>最大的问题是分析师降低了每股收益的预期，这表明 Appier Group 可能面临业务逆风。他们还下调了 Appier Group 的收入预期，但行业数据表明其预计增长速度仍将快于更广泛的行业。共识目标价明显下降，分析师似乎对最新结果并不感到安慰，导致对 Appier Group 未来估值的预期降低。</p>
<p>考虑到这一点，我们不会过于急于对 Appier Group 下结论。长期的盈利能力远比明年的利润更为重要。我们对 Appier Group 的预测一直延续到 2028 年，您可以在我们的平台上免费查看。</p>
<p>然而，在您过于兴奋之前，我们发现了 <strong>Appier Group 的 2 个警告信号</strong>，您应该注意。</p>
<h3><strong>新：在一个地方管理您的所有股票投资组合</strong></h3>
<p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>， <strong>而且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
<p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
<p>• 跟踪您股票的公允价值</p>
<p>免费试用演示投资组合</p>

4180

<p>Appier Group, Inc.（东京证券交易所代码：4180）的股价在发布年度报告后下跌了 21%，其收益低于预期 20%。分析师现在预测 2026 年的收入为 540 亿日元，增长 23%，但将每股收益预期下调至 48.59 日元。共识目标价下调 8.4% 至 1450 日元，反映出对收益前景下降的担忧。尽管与历史增长率相比增长放缓，Appier 仍预计将超过行业 9.9% 的增长。分析师已识别出该公司的两个警示信号，建议投资者保持谨慎</p>

<p>There's been a major selloff in <strong>Appier Group, Inc.</strong> (TSE:4180) shares in the week since it released its annual report, with the stock down 21% to JP¥794. It was not a great result overall. While revenues of JP¥44b were in line with analyst predictions, earnings were less than expected, missing statutory estimates by 20% to hit JP¥25.14 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.</p>
<div class="lb-trans"><p>自从 <strong>Appier Group, Inc.</strong> (TSE:4180) 发布年度报告以来，其股票经历了重大抛售，股价下跌 21%，至 JP¥794。整体结果并不理想。尽管 JP¥44 亿的收入符合分析师的预测，但盈利低于预期，未能达到法定估计，下降 20%，每股收益为 JP¥25.14。分析师通常会在每次财报发布时更新他们的预测，我们可以根据他们的估计判断他们对公司的看法是否发生了变化，或者是否有新的关注点。我们认为读者会发现分析师最新的（法定）财报后对明年的预测很有趣。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现的各个方面进行研发。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前投资。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/705511966-earnings-and-revenue-growth-1-dark-2/1771365243126" alt="" original-src="https://images.simplywall.st/asset/chart/705511966-earnings-and-revenue-growth-1-dark-2/1771365243126"/></p>
<p>TSE:4180 Earnings and Revenue Growth February 17th 2026</p>
<div class="lb-trans"><p>TSE:4180 收益和收入增长 2026 年 2 月 17 日</p>
</div><p>Following the latest results, Appier Group's six analysts are now forecasting revenues of JP¥54.0b in 2026. This would be a substantial 23% improvement in revenue compared to the last 12 months. Per-share earnings are expected to leap 94% to JP¥48.59. In the lead-up to this report, the analysts had been modelling revenues of JP¥55.3b and earnings per share (EPS) of JP¥52.50 in 2026. The analysts are less bullish than they were before these results, given the reduced revenue forecasts and the small dip in earnings per share expectations.</p>
<div class="lb-trans"><p>根据最新的结果，Appier Group 的六位分析师现在预测 2026 年的收入为 JP¥540 亿。这将比过去 12 个月的收入大幅增长 23%。每股收益预计将跃升 94%，达到 JP¥48.59。在发布此报告之前，分析师曾预测 2026 年的收入为 JP¥553 亿，每股收益（EPS）为 JP¥52.50。考虑到收入预测的减少和每股收益预期的小幅下降，分析师们的乐观程度不如之前。</p>
</div><p>View our latest analysis for Appier Group</p>
<div class="lb-trans"><p>查看我们对 Appier Group 的最新分析</p>
</div><p>The consensus price target fell 8.4% to JP¥1,450, with the weaker earnings outlook clearly leading valuation estimates. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Appier Group, with the most bullish analyst valuing it at JP¥1,800 and the most bearish at JP¥1,250 per share. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.</p>
<div class="lb-trans"><p>共识目标价下降了 8.4%，降至 JP¥1,450，疲软的盈利前景显然导致了估值预期的降低。然而，过于关注单一目标价可能是不明智的，因为共识目标实际上是分析师目标价的平均值。因此，一些投资者喜欢查看估计范围，以了解对公司估值是否存在分歧意见。对 Appier Group 的看法存在一些差异，最乐观的分析师将其估值为 JP¥1,800，而最悲观的分析师则为每股 JP¥1,250。显然，对该股票的看法存在不同，但我们认为估计范围并不够宽泛，以至于暗示情况无法预测。</p>
</div><p>Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. It's pretty clear that there is an expectation that Appier Group's revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 23% growth on an annualised basis. This is compared to a historical growth rate of 30% over the past five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 9.9% per year. So it's pretty clear that, while Appier Group's revenue growth is expected to slow, it's still expected to grow faster than the industry itself.</p>
<div class="lb-trans"><p>现在从更大的角度来看，我们可以通过将这些预测与过去的表现和行业增长预期进行比较来理解它们。显然，市场预期 Appier Group 的收入增长将大幅放缓，预计到 2026 年底的年化收入增长为 23%。相比之下，过去五年的历史增长率为 30%。与行业内其他有分析师覆盖的公司相比，后者预计年均收入增长为 9.9%。因此，尽管 Appier Group 的收入增长预计会放缓，但仍然预计会比行业整体增长得更快。</p>
</div><h2>The Bottom Line</h2>
<div class="lb-trans"><h2>结论</h2>
</div><p>The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Appier Group. They also downgraded Appier Group's revenue estimates, but industry data suggests that it is expected to grow faster than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of Appier Group's future valuation.</p>
<div class="lb-trans"><p>最大的问题是分析师降低了每股收益的预期，这表明 Appier Group 可能面临业务逆风。他们还下调了 Appier Group 的收入预期，但行业数据表明其预计增长速度仍将快于更广泛的行业。共识目标价明显下降，分析师似乎对最新结果并不感到安慰，导致对 Appier Group 未来估值的预期降低。</p>
</div><p>With that in mind, we wouldn't be too quick to come to a conclusion on Appier Group. Long-term earnings power is much more important than next year's profits. We have forecasts for Appier Group going out to 2028, and you can see them free on our platform here.</p>
<div class="lb-trans"><p>考虑到这一点，我们不会过于急于对 Appier Group 下结论。长期的盈利能力远比明年的利润更为重要。我们对 Appier Group 的预测一直延续到 2028 年，您可以在我们的平台上免费查看。</p>
</div><p>However, before you get too enthused, we've discovered <strong>2 warning signs for Appier Group</strong> that you should be aware of.</p>
<div class="lb-trans"><p>然而，在您过于兴奋之前，我们发现了 <strong>Appier Group 的 2 个警告信号</strong>，您应该注意。</p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新：在一个地方管理您的所有股票投资组合</strong></h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>， <strong>而且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪您股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

Appier Group, Inc. 刚刚未能达到盈利预期，但分析师们已经更新了他们的模型